Dengfeng Wang
Overview
Explore the profile of Dengfeng Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Z, Sun C, Heng H, Li J, Chen H, Chen F, et al.
Orthop Surg
. 2025 Jan;
PMID: 39844589
Objective: Inferior pole patellar fractures (IPPFs) pose a significant challenge due to their complex fracture patterns and high risk of complications associated with current treatment methods. This study aims to...
2.
Li W, Lian J, Wang D, Zhang S, Han C, Du Z, et al.
Materials (Basel)
. 2025 Jan;
18(1.
PMID: 39795716
In this study, FeCoNiCrSi (x = 0, 4, and 8) powders were successfully prepared using the aerosol method and employed to produce high-entropy coatings on Q235 steel via laser cladding....
3.
Li J, Mei B, Feng L, Wang X, Wang D, Huang J, et al.
iScience
. 2025 Jan;
27(12):111488.
PMID: 39759009
Reprogramming tryptophan metabolism (TRP) may be able to overcome immunosuppression and restore the immune checkpoint blockade (ICB) response in patients with epithelial ovarian cancer (EOC) resistant to ICB therapy because...
4.
Li J, Mei B, Zhu Y, Huang J, Li M, Wang D, et al.
Sci Rep
. 2024 Dec;
14(1):30945.
PMID: 39730678
MYD88 is an IL-6 primary response gene and, its upregulation of expression has been shown to be a poor prognostic factor in epithelial ovarian cancer (EOC). We investigated the effects...
5.
Mei B, Li J, Wang D, Feng L, Huang J, Zhang G
Mol Cancer Ther
. 2024 Dec;
24(3):453-463.
PMID: 39676352
Epithelial ovarian cancer (EOC) is the most lethal of gynecologic malignancies. The standard-of-care treatment for EOC is platinum-based chemotherapy such as cisplatin (CDDP). Notably, platinum-based chemotherapy induces resistance of EOC...
6.
Tian H, Zhang Y, Yang X, Zhang H, Wang D, Wu P, et al.
Ecotoxicol Environ Saf
. 2024 Oct;
285:117125.
PMID: 39369661
The entry of Cd into soil-rice systems is a growing concern as it can pose potential risks to public health. To derive regional soil Cd threshold, a total of 333...
7.
Zheng Q, Wang D, Gong X, Liu L, Wu H, Li Z, et al.
Int J Biol Macromol
. 2024 Jul;
277(Pt 1):134159.
PMID: 39059540
The development of high-performance biodegradable polylactic acid (PLA) materials integrating high strength, malleability and toughness is desired but an ongoing challenge. In this work, a novel full-biobased block copolymer was...
8.
Wang D, Shi X, Pei J, Zhang C, Peng L, Zhang J, et al.
Chin Med J (Engl)
. 2024 Apr;
PMID: 38679485
Background: Poly adenosine-diphosphate-ribose polymerase (PARP) inhibitors (PARPi) have been approved to act as first-line maintenance (FL-M) therapy and as platinum-sensitive recurrent maintenance (PSR-M) therapy for ovarian cancer in China for...
9.
Yan G, Wei Y, Wang D, Wang D, Ren H, Hou B
J Neurotrauma
. 2024 Mar;
41(15-16):1813-1826.
PMID: 38497747
Sleepwake disturbances (SWDs) are one of the most common complaints following traumatic brain injury (TBI). The high prevalence and socioeconomic burden of SWDs post-TBI have only been recognized in the...
10.
Zhang J, Wang D, Peng L, Shi X, Shi Y, Zhang G
Eur J Surg Oncol
. 2024 Mar;
50(4):108230.
PMID: 38430704
Objective: The primary objective of this study is to explore the preoperative risk factors of pelvic lymph node metastasis (PLNM) in endometrial cancer patients, and construct a nomogram prediction model....